Form C - Offering Statement:
SEC Accession No. 0001670254-24-000815
Filing Date
2024-08-06
Accepted
2024-08-05 19:40:51
Documents
15

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11688
2 document_1.pdf EX-99 5882742
3 document_2.pdf EX-99 3048793
4 document_3.pdf EX-99 13031531
5 document_4.pdf EX-99 9873637
6 document_5.pdf EX-99 8934146
7 document_6.pdf EX-99 8934501
8 document_7.pdf EX-99 7318642
9 document_8.pdf EX-99 2744427
10 document_9.pdf EX-99 1814874
11 document_10.pdf EX-99 1568129
12 document_11.pdf EX-99 1720137
13 document_12.pdf EX-99 68759
14 document_13.pdf EX-99 4701160
15 documents_list.htm EX-99 123
  Complete submission text file 0001670254-24-000815.txt   94155708
Mailing Address 1 IRVING PLACE SUITE P8C NEW YORK NY 10003
Business Address 1 IRVING PLACE SUITE P8C NEW YORK NY 10003 917-653-9922
Arcade Therapeutics, Inc. (Filer) CIK: 0002007059 (see all company filings)

EIN.: 843286681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-34549 | Film No.: 241176571